INTRODUCTION 5 8
The availability of field-deployable malaria rapid diagnostic tests (RDTs) in recent 1 3 8 °C and protected from light. Microspheres were blocked with PBS-BN (PBS with 1% 1 3 9 BSA and 0.05% sodium azide (Sigma, Tres Cantos, Spain) , and re-suspended in PBS- 1:1000 in assay buffer for 30 minutes in gentle agitation in the dark. Finally, the beads 1 5 0
were washed and re-suspended in assay buffer, and the plate was read using the 1 5 1
Luminex xMAP® 100/200 analyser (Luminex Corp., Austin, TX). A reading higher 1 5 2 than 25000 median fluorescence intensity (MFI) implied a successful coupling reaction. Coupled beads were stored multiplexed at a concentration of 1000 beads/µl/region at 4 1 5 4
°C and protected from light. To optimize the coupling concentration of detection antibodies, a concentration range 1 5 6 from 10 to 100 µg/ml of α -PfHRP2 and α -PAN-pLDH monoclonal antibodies (mAbs) quantified, and the obtained antigen concentrations in pg/ml were used to calculate the 1 7 5 number of antigen picograms corresponding to 1 International Unit (IU). in assay buffer to produce standard curves ranging from 50,000 to 0.024 pg/ml for 1 8 0 9 PfHRP2, and from 1,000,000 to 0.48 for both P. falciparum pLDH and Pv pLDH 1 8 1 ( Figure 1B ) (for a more detailed assay procedure, see Additional file 1: Text2). To quantify the LLOD and the LLOQ, 3 and 6 standard deviations (SD) were added to 1 9 7 the mean MFI of blanks (n = 132), respectively. Each calibration or standard curve was 1 9 8 fitted using a five parameters logistic (5PL) regression, and the mean curve was 1 9 9 calculated. To present the LLOD and the LLOQ as concentration values, the calculated 2 0 0 MFI values were interpolated to the mean calibration curve. diving the difference between the experimental value and the expected value and then 2 0 9 multiplying by 100. Acceptable accuracy was defined as the %DEV not surpassing by
20% the expected concentration (by 25% for samples with concentrations falling at the 2 1 1 LLOQ and ULOQ). Precision. Intra-assay and inter-assay precision were evaluated by assaying cultured P. The % CV for each sample was calculated by determining the standard deviation (SD) samples from 25 Spanish pregnant women never exposed to malaria were assayed to 2 2 5 demonstrate that the bead suspension array does not detect plasma components other 2 2 6 than the target antigens (PfHRP2 and pLDH). To test against samples collected in endemic areas, different sample sets were assayed 2 2 9
(characteristics of clinical samples used are summarized in Table 1 ). conditions. Culture in exponential growth phase was harvested, infected red blood cells 2 3 3
were spun down, aliquoted, and frozen at -80 °C as previously described (21).
Plasmodium vivax isolates were collected from symptomatic adult volunteers with a P. time points from 25 pregnant women never exposed to malaria, who attended the Limit of detection, limits of quantification and range. The lower limit of detection 3 0 2
(LLOD) of the assay was determined to be 6.0, 56.1 and 1093.20 pg/ml for recombinant 3 0 3
PfHRP2 type A, P. falciparum pLDH and P. vivax pLDH respectively; and the lower 3 0 4 limit of the quantification (LLOQ) was estimated at 6.8 pg/ml for PfHRP2, 78.1 pg/ml 3 0 5
for P. falciparum pLDH and 1343.5 pg/ml for P. vivax pLDH. The ULOQ was found to decreased both for PfHRP2 and P. falciparum pLDH detection as shown in Table 2 .
Precision. Intra-assay variation was 8.3% and 9.8% for PfHRP2 and pLDH, respectively. The inter-assay %CV was 8.4% for the detection of PfHRP2 and 11.2% within the acceptance criteria of 15% and of 20 % variation, respectively (30). To determine the loss of antigen when recovering PfHRP2 and pLDH from filter papers 3 2 5 as compared to same volumes of whole blood samples, DBS were prepared with whole 3 2 6 blood samples from Senegalese and Peruvian asymptomatic individuals (See Table 1 ). Assay selectivity for the target antigens values than the LLOQ for pLDH and PfHRP2 respectively. In addition, two P. falciparum positive samples with pfhrp2 deletion showed MFI values above the LLOQ. negligible fluorescence signals for both antigens (Figure 2 ).
3 5 0
Correlation between antigen levels and parasite densities
3 5 1
In samples positive for one or two antigens, the correlation between antigen (Spearman r = 0.40; p < 0.0001) ( Figure 3 ). pLDH levels showed a higher correlation 3 5 6
with parasite densities compared to PfHRP2, both in samples for which densities were levels differed across the different sample sets analysed (See Additional file 3: Table   3 6 0 S1). Interestingly, the correlation between pLDH levels with parasite densities in whole compared to samples from Peru (Spearman r = 0.20; p = 0.0308). In the present study, we have established a quantitative suspension array based on precision, and can be used to effectively and rapidly quantify malaria antigens in large 3 7 5
quantities of different biosamples. The performance of the bead suspension array to quantify PfHRP2 and pLDH was 3 7 7 evaluated using reference recombinant proteins as well as cultured parasites, and in 3 7 8 different biofluids from malaria exposed and malaria naïve individuals. The assay is 3 7 9
selective for the target antigens and has an analytical range of 6.8 to 762.8 and of 78. technologies (20, 28) . This suggests that with the current technology available for the 3 8 5 quantification of PfHRP2 using antibodies, the lowest limit of detection achievable is in 3 8 6 the range of 0.5 to 10 pg/ml. The limit of detection for pLDH is more divergent across 3 8 7 assays, ranging from approximately 10 pg/ml (28) up to 4000 pg/ml (25), but in all 3 8 8 assays it is always higher than that for PfHRP2. This underpins the need to further 3 8 9
improve the sensitivity of pLDH-based diagnostics.
The bead suspension array described here can successfully be used as for detection and 3 9 1 quantification of PfHRP2 and pLDH in whole blood, eluted DBS and plasma or serum (40). Differently, for pLDH we found that antigen concentration in eluted DBS 3 9 5 corresponds to a 1:60 whole blood dilution, which differs from previously published 3 9 6
data showing no differences in antigen recovery between PfHRP2 and pLDH (20). However, such differences could be explained by the different extraction methodologies 3 9 8
and storage conditions used. confer increased reactivity to mAbs in RDTs (41, 42) . According to this classification,
PfHRP2 Type A comprises the higher number of repeat types 2 and 7, followed by We observed an overall positive significant correlation between antigen levels and differently from pLDH, is secreted to the blood stream and persists in circulation for 4 2 1 several days. In addition, we observed that the correlation between PfHRP2 and parasite 4 2 2 20 temperature; SD: standard deviation; Sulfo-NHS (N-hydroxysulfosuccinimide); ULOQ: We thank the study participants; the staff of the Hospitals, clinical officers, field The authors declare that they have no competing interests. The datasets used and/or analysed during the current study are available from the Identify Plasmodium knowlesi Infection. tests. PLoS One. 2017;12(2):e0172139.
